首页 > 最新文献

Annals of Cancer Research and Therapy最新文献

英文 中文
Skeletal muscle mass assessment in critically ill patients: method and application 危重病人骨骼肌质量评估:方法与应用
Q4 Medicine Pub Date : 2022-07-21 DOI: 10.4993/acrt.30.93
Kohei Tanaka, Shouhei Katayama, K. Okura, Masatsugu Okamura, K. Nawata, N. Nakanishi, A. Shinohara
{"title":"Skeletal muscle mass assessment in critically ill patients: method and application","authors":"Kohei Tanaka, Shouhei Katayama, K. Okura, Masatsugu Okamura, K. Nawata, N. Nakanishi, A. Shinohara","doi":"10.4993/acrt.30.93","DOIUrl":"https://doi.org/10.4993/acrt.30.93","url":null,"abstract":"","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44461315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
The clinical effect of total mesorectal excision with lateral lymph node dissection for lower rectal cancer: A systematic review and meta-analysis 直肠全系膜切除加外侧淋巴结清扫治疗下直肠癌症的临床疗效:系统回顾和荟萃分析
Q4 Medicine Pub Date : 2022-07-21 DOI: 10.4993/acrt.30.106
Hidetaka Kawamura, T. Miyakawa, Y. Tsujimoto, R. Yamamoto, Norio Watanabe, M. Honda
{"title":"The clinical effect of total mesorectal excision with lateral lymph node dissection for lower rectal cancer: A systematic review and meta-analysis","authors":"Hidetaka Kawamura, T. Miyakawa, Y. Tsujimoto, R. Yamamoto, Norio Watanabe, M. Honda","doi":"10.4993/acrt.30.106","DOIUrl":"https://doi.org/10.4993/acrt.30.106","url":null,"abstract":"","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47338167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Soluble MICA in Biofluids as Biomarker in Tracing Oral Malignant Growth Which Relates with Disease Stage 生物体液中可溶性MICA作为追踪口腔恶性肿瘤生长与疾病分期相关的生物标志物
Q4 Medicine Pub Date : 2022-07-21 DOI: 10.4993/acrt.30.131
Jeevitaa R. Kshersagar, Mrunal N. Damle, Poonam A. Bedge, Rakhi V. Jagdale, Kishor R. Tardalkar, Swapnali Jagadale, D. Jadhav, Yashwant Toro, M. Joshi
{"title":"Soluble MICA in Biofluids as Biomarker in Tracing Oral Malignant Growth Which Relates with Disease Stage","authors":"Jeevitaa R. Kshersagar, Mrunal N. Damle, Poonam A. Bedge, Rakhi V. Jagdale, Kishor R. Tardalkar, Swapnali Jagadale, D. Jadhav, Yashwant Toro, M. Joshi","doi":"10.4993/acrt.30.131","DOIUrl":"https://doi.org/10.4993/acrt.30.131","url":null,"abstract":"","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42621256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary malignant pericardial mesothelioma in a patient with a history of thoracic radiotherapy and asbestos exposure: A case report 一例有胸部放射治疗和石棉暴露史的原发性恶性心包间皮瘤病例报告
Q4 Medicine Pub Date : 2022-01-31 DOI: 10.4993/acrt.30.18
Yoko Touyama, K. Hirano, Einosuke Ono, Y. Abe, Tatsuya Shirai, A. Mouri, Atsushi Sakakibara, M. Ohno, Toshiya Inui, K. Suhara, M. Kamimura
{"title":"Primary malignant pericardial mesothelioma in a patient with a history of thoracic radiotherapy and asbestos exposure: A case report","authors":"Yoko Touyama, K. Hirano, Einosuke Ono, Y. Abe, Tatsuya Shirai, A. Mouri, Atsushi Sakakibara, M. Ohno, Toshiya Inui, K. Suhara, M. Kamimura","doi":"10.4993/acrt.30.18","DOIUrl":"https://doi.org/10.4993/acrt.30.18","url":null,"abstract":"","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45890491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Leucopenia induced by tamoxifen in a breast cancer patient: a case report 三苯氧胺诱导癌症患者白细胞减少1例报告
Q4 Medicine Pub Date : 2022-01-31 DOI: 10.4993/acrt.30.8
Y. Al-Bairmany
{"title":"Leucopenia induced by tamoxifen in a breast cancer patient: a case report","authors":"Y. Al-Bairmany","doi":"10.4993/acrt.30.8","DOIUrl":"https://doi.org/10.4993/acrt.30.8","url":null,"abstract":"","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41330890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A feasibility study for smartphone application to evaluate dietary realities after gastrointestinal surgery 智能手机应用评估胃肠手术后饮食现实的可行性研究
Q4 Medicine Pub Date : 2022-01-31 DOI: 10.4993/acrt.30.33
M. Honda, Muhammad Wannous, Kazumichi Yamamoto, Akiko Yoshida
{"title":"A feasibility study for smartphone application to evaluate dietary realities after gastrointestinal surgery","authors":"M. Honda, Muhammad Wannous, Kazumichi Yamamoto, Akiko Yoshida","doi":"10.4993/acrt.30.33","DOIUrl":"https://doi.org/10.4993/acrt.30.33","url":null,"abstract":"","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42055214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The patient, diagnosis and treatment delay of the care pathway of patients with breast Cancer in Morocco 摩洛哥乳腺癌患者护理路径的患者、诊断和治疗延迟
Q4 Medicine Pub Date : 2022-01-31 DOI: 10.4993/acrt.30.11
Hind Mimouni, K. Hassouni, Boujemaa EL Marnissi, Bouchra Haddou Rahou, L. Alaoui, R. Ismaili, A. Hilali, A. Nejmeddine, R. Bekkali, Leila Loukili
{"title":"The patient, diagnosis and treatment delay of the care pathway of patients with breast Cancer in Morocco","authors":"Hind Mimouni, K. Hassouni, Boujemaa EL Marnissi, Bouchra Haddou Rahou, L. Alaoui, R. Ismaili, A. Hilali, A. Nejmeddine, R. Bekkali, Leila Loukili","doi":"10.4993/acrt.30.11","DOIUrl":"https://doi.org/10.4993/acrt.30.11","url":null,"abstract":"","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44825749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of TERT promoter mutations in tumor biopsies and urine sediment of Moroccan bladder cancer patients 摩洛哥癌症患者肿瘤活检和尿中TERT启动子突变的评估
Q4 Medicine Pub Date : 2022-01-31 DOI: 10.4993/acrt.30.1
Chaimae Hafidi Alaoui, H. El ahanidi, M. El Azzouzi, A. Filali-Maltouf, I. Chaoui, M. Bensaid, L. Benbacer, Mohammed Tetou, Ilias Hassan, M. Oukabli, A. Ameur, A. Al bouzidi, Mohammed Attaleb, M. El Mzibri
Background: Human telomerase reverse transcriptase (hTERT) promoter mutations are common genetic events in blad- der cancer (BC) and have been recognized as potential biomarkers for BC diagnosis and prognosis. Detection of TERT promoter mutations as urine-based tests has previously been reported to detect primary and recurrent BC. This study was planned to evaluate hTERT promoter mutations in both biopsies and urines from BC patients to assess the interest and the usefulness of introducing these biomarkers for better management of BC in Morocco. Methods: In a cohort study involving a series of BC 70 patients with different stages and grades, hTERT promoter mutations were identified in both fresh biopsies and urine sediments by PCR amplification and DNA sequencing. Results: Overall, hTERT promoter mutations were reported in 60% of cancer biopsies (42/70), the hotspot mutations C228T and C250T were respectively identified in 80.95% (34/42) and 16.67% (7/42) of positive cases. Other mutations: A161C and G149T were also reported and were obtained in 2.38% (1/42) and 2.38% (1/42), respectively. hTERT promoter mutations were identified in 30% of matched urine sediments (21/70) and showed an overall sensitivity of 50% and specificity of 100%. In patients with non-muscle invasive bladder cancer, no statistically significant association was detected between TERT promoter mutations and recurrence-free survival (HR: 1.224, 95% CI: 0.373–4.011, p = 0.739), and overall survival (HR: 0.363, 95% CI: 0.041–3.244, p = 0.364). Conclusion: hTERT promoter mutations are early events occurring with high frequencies and can be identified in the exfo- liated cells, making them an interesting non-invasive biomarker for diagnosis and follow-up of bladder cancer.
人类端粒酶逆转录酶(hTERT)启动子突变是膀胱癌(BC)中常见的遗传事件,已被认为是膀胱癌诊断和预后的潜在生物标志物。检测TERT启动子突变作为基于尿液的测试,以前曾报道过检测原发性和复发性BC。本研究计划评估BC患者活检和尿液中的hTERT启动子突变,以评估在摩洛哥引入这些生物标志物以更好地管理BC的兴趣和有用性。方法:在一项涉及一系列不同分期和分级的BC 70患者的队列研究中,通过PCR扩增和DNA测序在新鲜活检和尿液沉积物中发现hTERT启动子突变。结果:总体而言,60%的肿瘤活检报告了hTERT启动子突变(42/70),阳性病例中分别有80.95%(34/42)和16.67%(7/42)发现了热点突变C228T和C250T。其他突变:A161C和G149T也有报道,分别为2.38%(1/42)和2.38%(1/42)。hTERT启动子突变在30%(21/70)的匹配尿液沉积物中被鉴定出来,总体敏感性为50%,特异性为100%。在非肌性浸润性膀胱癌患者中,TERT启动子突变与无复发生存率(HR: 1.224, 95% CI: 0.373 ~ 4.011, p = 0.739)和总生存率(HR: 0.363, 95% CI: 0.041 ~ 3.244, p = 0.364)无统计学意义相关。结论:hTERT启动子突变是发生频率高的早期事件,可在膀胱癌外移细胞中被识别,是膀胱癌诊断和随访的一种有趣的非侵入性生物标志物。
{"title":"Evaluation of TERT promoter mutations in tumor biopsies and urine sediment of Moroccan bladder cancer patients","authors":"Chaimae Hafidi Alaoui, H. El ahanidi, M. El Azzouzi, A. Filali-Maltouf, I. Chaoui, M. Bensaid, L. Benbacer, Mohammed Tetou, Ilias Hassan, M. Oukabli, A. Ameur, A. Al bouzidi, Mohammed Attaleb, M. El Mzibri","doi":"10.4993/acrt.30.1","DOIUrl":"https://doi.org/10.4993/acrt.30.1","url":null,"abstract":"Background: Human telomerase reverse transcriptase (hTERT) promoter mutations are common genetic events in blad- der cancer (BC) and have been recognized as potential biomarkers for BC diagnosis and prognosis. Detection of TERT promoter mutations as urine-based tests has previously been reported to detect primary and recurrent BC. This study was planned to evaluate hTERT promoter mutations in both biopsies and urines from BC patients to assess the interest and the usefulness of introducing these biomarkers for better management of BC in Morocco. Methods: In a cohort study involving a series of BC 70 patients with different stages and grades, hTERT promoter mutations were identified in both fresh biopsies and urine sediments by PCR amplification and DNA sequencing. Results: Overall, hTERT promoter mutations were reported in 60% of cancer biopsies (42/70), the hotspot mutations C228T and C250T were respectively identified in 80.95% (34/42) and 16.67% (7/42) of positive cases. Other mutations: A161C and G149T were also reported and were obtained in 2.38% (1/42) and 2.38% (1/42), respectively. hTERT promoter mutations were identified in 30% of matched urine sediments (21/70) and showed an overall sensitivity of 50% and specificity of 100%. In patients with non-muscle invasive bladder cancer, no statistically significant association was detected between TERT promoter mutations and recurrence-free survival (HR: 1.224, 95% CI: 0.373–4.011, p = 0.739), and overall survival (HR: 0.363, 95% CI: 0.041–3.244, p = 0.364). Conclusion: hTERT promoter mutations are early events occurring with high frequencies and can be identified in the exfo- liated cells, making them an interesting non-invasive biomarker for diagnosis and follow-up of bladder cancer.","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47047384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcome of omentectomy for patients with pT3 gastric cancer pT3期胃癌大网膜切除术的远期疗效分析
Q4 Medicine Pub Date : 2022-01-31 DOI: 10.4993/acrt.30.45
Yukiko Nonaka, T. Seki, Satomi Saeki, N. Uemura, T. Ito, Masahiro Tanaka, Koki Tabata, Hiromasa Yamashita, T. Arai, Takeshi Amemiya
{"title":"Long-term outcome of omentectomy for patients with pT3 gastric cancer","authors":"Yukiko Nonaka, T. Seki, Satomi Saeki, N. Uemura, T. Ito, Masahiro Tanaka, Koki Tabata, Hiromasa Yamashita, T. Arai, Takeshi Amemiya","doi":"10.4993/acrt.30.45","DOIUrl":"https://doi.org/10.4993/acrt.30.45","url":null,"abstract":"","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45410348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Primary hepatic neuroendocrine carcinoma: A postoperative diagnosis 原发性肝神经内分泌癌的术后诊断
Q4 Medicine Pub Date : 2022-01-31 DOI: 10.4993/acrt.30.28
Cuong Nguyen Pham, Thanh Hai Phan, X. Nguyễn, Hoang Thanh Cao, Hien Nhu Pham, Anh Hoai Vu
{"title":"Primary hepatic neuroendocrine carcinoma: A postoperative diagnosis","authors":"Cuong Nguyen Pham, Thanh Hai Phan, X. Nguyễn, Hoang Thanh Cao, Hien Nhu Pham, Anh Hoai Vu","doi":"10.4993/acrt.30.28","DOIUrl":"https://doi.org/10.4993/acrt.30.28","url":null,"abstract":"","PeriodicalId":35647,"journal":{"name":"Annals of Cancer Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43404741","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Cancer Research and Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1